Addressing drug shortages has been identified as a top priority for the Government of Canada. A multi stakeholder task team has been assembled to ensure patient access and prevent the detrimental impact of these shortages on the health of Canadians.

This session will examine ongoing work by the task team, including:

• Assessing the scale and potential impact of a drug shortage
• Determining if the shortage for a drug or group of drugs is considered severe (Tier 3)
• Providing timely communication and engage stakeholders through the creation of a national drug shortage list
• Working with stakeholders to develop drug shortage and supply chain disruption mitigation strategies
  • Examining opportunities to fast-track regulatory reviews or allow for drug importation
• Identifying how healthcare providers can play a role and where manufacturers not being impacted can assist with supply